Your browser doesn't support javascript.
loading
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?
Schennach, R; Riesbeck, M; Mayr, A; Seemüller, F; Maier, W; Klingberg, S; Heuser, I; Klosterkötter, J; Gastpar, M; Schmitt, A; Sauer, H; Schneider, F; Jäger, M; Wölwer, W; Gaebel, W; Möller, H-J; Riedel, M.
Afiliación
  • Schennach R; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich Department of Psychiatry and Psychotherapy, University of Göttingen, Germany. rebecca.schennach@med.uni-muenchen.de
Acta Psychiatr Scand ; 127(6): 474-81, 2013 Jun.
Article en En | MEDLINE | ID: mdl-22957829
OBJECTIVE: To evaluate the predictive validity of early response in first-episode schizophrenia within a 1-year follow-up trial and to compare the resulting cutoff to the currently proposed early response definition (20% improvement by week 2). METHOD: Receiver operator characteristic (ROC) analyses were used to identify the predictive validity of the psychopathological improvement of treatment from week 1 to week 8, regarding the maintenance of response until week 52 as well as to define the most reasonable cutoff in 132 first-episode patients. The Youden Index (maximum of sensitivity and specificity) was used to compare the newly developed and the commonly used early response definition. RESULTS: Starting with week 6, a reasonable validity to predict the maintenance of response was found (area under the curve = 0.721) with the best fitting cutoff being a 51.6% PANSS total score improvement. Using this cutoff 74 patients (56%) were correctly identified to become responder and maintain response during follow-up (sensitivity: 0.747). The Youden Index was higher applying the newly developed early response cutoff featuring higher specificity compared to the commonly used early response definition. CONCLUSION: Regarding long-term treatment, it seems more appropriate to base predictions of the patient's maintenance of response not before 6 weeks of treatment.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Risperidona / Haloperidol Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Acta Psychiatr Scand Año: 2013 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Risperidona / Haloperidol Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Acta Psychiatr Scand Año: 2013 Tipo del documento: Article País de afiliación: Alemania